Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19 : A Randomized, Placebo-Controlled Trial.
Matthew G JohnsonAmy PuenpatomPablo Andrés MoncadaLesley BurgessElizabeth R DukeNorio OhmagariTimo WolfMatteo BassettiSanjay BhaganiJade GhosnYing ZhangHong WanAngela Williams-DiazMichelle L BrownAmanda PaschkeCarisa De AndaPublished in: Annals of internal medicine (2022)
Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc.